Drivers of disability in MS
Dr Jeffrey Dunn discusses what drives disability in MS at ACTRIMS Forum 2024.
Jeffrey Dunn, MD
Department of Neurology and Neurological Sciences, Stanford University
Stanford, CA, USA
Dr Dunn was compensated for this presentation.
This independent Industry Showcase was not included in the ACTRIMS Forum accredited program. No CE credit was provided.
Disability accumulation and PIRA
Professor Massimo Filippi discusses disability accumulation and PIRA at ECTRIMS 2023.
Massimo Filippi, MD, FEAN, FAAN
Vita-Salute San Raffaele University
Milan, Italy
Professor Filippi was compensated for this presentation.
The onset of smoldering neuroinflammation
Dr Bhupendra O. Khatri discusses the onset of smoldering neuroinflammation at the 2023 AAN Annual Meeting.
Bhupendra O. Khatri, MD, FAAN
The Center for Neurological Disorders
Milwaukee, USA
Dr Khatri was compensated for this presentation.
The underlying biology of acute and smoldering neuroinflammation
Professor Celia Oreja-Guevara discusses the underlying biology of acute and smoldering neuroinflammation at EAN 2023.
Celia Oreja-Guevara, MD, PhD
Vice Chair of Neurology, Head of Multiple Sclerosis Center at the University Hospital San Carlos
Associate Professor of Neurology at the Complutense University
Madrid, Spain
Professor Oreja-Guevara was compensated for this presentation.
Microglial activation in MS
Professor Heinz Wiendl discusses microglial activation in MS at ECTRIMS 2023.
Heinz Wiendl, MD, PhD, FEAN, FAAN
Department of Neurology, University of Münster
Münster, Germany
Professor Wiendl was compensated for this presentation.
Insights from the Experts
Read a consensus paper on smoldering-associated worsening and its implication in practice